MARKET

UTMD

UTMD

Utah Med Prod
NASDAQ

Real-time Quotes | Nasdaq Last Sale

87.77
-1.23
-1.38%
Closed 16:00 09/20 EDT
OPEN
88.92
PREV CLOSE
89.00
HIGH
90.06
LOW
87.10
VOLUME
36.02K
TURNOVER
--
52 WEEK HIGH
95.65
52 WEEK LOW
77.80
MARKET CAP
320.06M
P/E (TTM)
24.56
1D
5D
1M
3M
1Y
5Y
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.28
The board of Utah Medical Products, Inc. ( NASDAQ:UTMD ) has announced that it will pay a dividend of US$0.28 per share...
Simply Wall St. · 09/10 14:15
Up More Than 200% in the Past Three Months, is NanoVibronix Still a Buy?
StockNews.com · 09/02 13:13
What Kind Of Shareholders Hold The Majority In Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shares?
If you want to know who really controls Utah Medical Products, Inc. ( NASDAQ:UTMD ), then you'll have to look at the...
Simply Wall St. · 08/20 19:53
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / August 3, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on October 5,...
ACCESSWIRE · 08/03 14:00
Summers Value Partners on Utah Medical (UTMD): “We Believe the Company’s Business is Poised to Rebound”
Summers Value Partners, an investment management firm, published its “Summers Value Fund” second quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly return of 13.6% net of fees, was recorded by the fund for the second quarter...
Insider Monkey · 08/02 16:47
BRIEF-Utmd Reports Financial Performance For Second Calendar Quarter And First Half 2021
reuters.com · 07/22 13:36
Utah Medical Products reports Q2 results
Utah Medical Products (UTMD): Q2 Non-GAAP EPS of $1.04; GAAP EPS of $0.94.Revenue of $12.6M (+43.3% Y/Y)Press Release
Seekingalpha · 07/22 13:13
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021
Salt Lake City, Utah, July 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.’s (Nas...
GlobeNewswire · 07/22 13:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of UTMD. Analyze the recent business situations of Utah Med Prod through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Institutional Holdings
Institutions: 106
Institutional Holdings: 2.70M
% Owned: 74.16%
Shares Outstanding: 3.65M
TypeInstitutionsShares
Increased
25
115.59K
New
3
5.93K
Decreased
27
107.69K
Sold Out
15
46.49K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.45%
Healthcare Equipment & Supplies
-1.59%
Key Executives
Chairman/President/Chief Executive Officer/Secretary/Director
Kevin Cornwell
Chief Financial Officer
Brian Koopman
Lead Director/Independent Director
Ernst Hoyer
Director
Paul Richins
Independent Director
James Beeson
Independent Director
Barbara Payne
Declaration Date
Dividend Per Share
Ex-Div Date
08/03/2021
Dividend USD 0.285
09/15/2021
05/11/2021
Dividend USD 0.285
06/14/2021
02/09/2021
Dividend USD 0.285
03/16/2021
11/03/2020
Dividend USD 0.285
12/14/2020
08/11/2020
Dividend USD 0.28
09/14/2020
05/07/2020
Dividend USD 0.28
06/16/2020
02/13/2020
Dividend USD 0.28
03/12/2020
11/05/2019
Dividend USD 0.28
12/12/2019
08/08/2019
Dividend USD 0.275
09/12/2019
05/07/2019
Dividend USD 0.275
06/13/2019
02/12/2019
Dividend USD 0.275
03/14/2019
10/30/2018
Dividend USD 0.275
12/13/2018
07/31/2018
Dividend USD 0.27
09/13/2018
05/08/2018
Dividend USD 0.27
06/14/2018
02/13/2018
Dividend USD 0.27
03/15/2018
10/31/2017
Dividend USD 0.27
12/14/2017
08/01/2017
Dividend USD 0.265
09/14/2017
05/09/2017
Dividend USD 0.265
06/14/2017
02/07/2017
Dividend USD 0.265
03/15/2017
11/01/2016
Dividend USD 0.265
12/14/2016
About UTMD
Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company's product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women's health center in hospitals, as well as products sold to outpatient clinics and physician's offices.

Webull offers kinds of Utah Medical Products, Inc. stock information, including NASDAQ:UTMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UTMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading UTMD stock methods without spending real money on the virtual paper trading platform.